Margaret R. Duffy

883 total citations
25 papers, 705 citations indexed

About

Margaret R. Duffy is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Margaret R. Duffy has authored 25 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 17 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Margaret R. Duffy's work include Virus-based gene therapy research (19 papers), CAR-T cell therapy research (12 papers) and Viral Infectious Diseases and Gene Expression in Insects (11 papers). Margaret R. Duffy is often cited by papers focused on Virus-based gene therapy research (19 papers), CAR-T cell therapy research (12 papers) and Viral Infectious Diseases and Gene Expression in Insects (11 papers). Margaret R. Duffy collaborates with scholars based in United Kingdom, United States and Netherlands. Margaret R. Duffy's co-authors include Leonard W. Seymour, Joshua D. Freedman, Eleanor M. Scott, Andrew H. Baker, Kerry D. Fisher, Alan L. Parker, Angela C. Bradshaw, Brian Champion, Stuart A. Nicklin and Joachim Hagel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Margaret R. Duffy

23 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Margaret R. Duffy United Kingdom	14	500	445	386	134	90	25	705
Sari Pesonen Finland	20	659 1.3×	700 1.6×	537 1.4×	125 0.9×	107 1.2×	33	1.1k
Minna Oksanen Finland	17	726 1.5×	666 1.5×	367 1.0×	210 1.6×	113 1.3×	24	884
Yingshu Zhang China	11	379 0.8×	243 0.5×	308 0.8×	71 0.5×	39 0.4×	19	561
Mari Hirvinen Finland	13	651 1.3×	550 1.2×	361 0.9×	236 1.8×	113 1.3×	19	878
Timo Joensuu Finland	18	716 1.4×	668 1.5×	367 1.0×	190 1.4×	118 1.3×	27	893
Víctor Cervera-Carrascón Finland	18	513 1.0×	597 1.3×	249 0.6×	245 1.8×	65 0.7×	40	761
Nikolay Korokhov United States	16	512 1.0×	294 0.7×	474 1.2×	214 1.6×	119 1.3×	26	829
Cristian Capasso Finland	16	324 0.6×	323 0.7×	388 1.0×	210 1.6×	72 0.8×	23	709
Shyambabu Chaurasiya United States	18	414 0.8×	406 0.9×	203 0.5×	128 1.0×	86 1.0×	33	636
Suvi Sorsa Finland	13	486 1.0×	623 1.4×	239 0.6×	220 1.6×	59 0.7×	22	725

Countries citing papers authored by Margaret R. Duffy

Since Specialization

Citations

This map shows the geographic impact of Margaret R. Duffy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret R. Duffy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret R. Duffy more than expected).

Fields of papers citing papers by Margaret R. Duffy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret R. Duffy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret R. Duffy. The network helps show where Margaret R. Duffy may publish in the future.

Co-authorship network of co-authors of Margaret R. Duffy

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret R. Duffy. A scholar is included among the top collaborators of Margaret R. Duffy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret R. Duffy. Margaret R. Duffy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moriconi, Chiara, Tracey Perry, Paula Cunnea, et al.. (2024). 1283 Oncolytic immunotherapy THEO-260 enters readiness for first in human clinical trial in ovarian cancer patients. Regular and Young Investigator Award Abstracts. A1438–A1438. 1 indexed citations

Frost, Susan C., Chiara Moriconi, Tracy Perry, et al.. (2023). 2271P Development of an oncolytic virus for the treatment of high grade serous ovarian cancer and other stromal rich tumours. Annals of Oncology. 34. S1166–S1166. 2 indexed citations

Krell, Jonathan, Chiara Moriconi, Deanna Saunders, et al.. (2023). Evaluation of THEO-260 as a novel oncolytic virus therapy for treating stromal rich tumours.. Journal of Clinical Oncology. 41(16_suppl). e14573–e14573. 1 indexed citations

Su, Weiheng, et al.. (2022). Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination. Nature Communications. 13(1). 1182–1182. 26 indexed citations

Duffy, Margaret R., et al.. (2022). Lamotrigine Causing Drug-Induced Acute Interstitial Nephritis With Granulomas. Journal of the American Society of Nephrology. 33(11S). 86–86.

Scott, Eleanor M., Brian Lyons, Joshua D. Freedman, et al.. (2019). Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples. Journal for ImmunoTherapy of Cancer. 7(1). 320–320. 64 indexed citations

Freedman, Joshua D., Margaret R. Duffy, Janet Lei-Rossmann, et al.. (2018). An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells. Cancer Research. 78(24). 6852–6865. 135 indexed citations

Lei-Rossmann, Janet, Kerry D. Fisher, Silvio Hemmi, et al.. (2018). Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells. Journal for ImmunoTherapy of Cancer. 6(1). 55–55. 15 indexed citations

Duffy, Margaret R., Kerry D. Fisher, & Leonard W. Seymour. (2017). Making Oncolytic Virotherapy a Clinical Reality: The European Contribution. Human Gene Therapy. 28(11). 1033–1046. 12 indexed citations

10.

Scott, Eleanor M., Margaret R. Duffy, Joshua D. Freedman, Kerry D. Fisher, & Leonard W. Seymour. (2017). Solid Tumor Immunotherapy with T Cell Engager‐Armed Oncolytic Viruses. Macromolecular Bioscience. 18(1). 60 indexed citations

11.

Di, Ying, Maxine Bauzon, Janet Lei-Rossmann, et al.. (2017). Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus. Molecular Therapy — Oncolytics. 5. 62–74. 40 indexed citations

12.

Freedman, Joshua D., Joachim Hagel, Eleanor M. Scott, et al.. (2017). Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies. EMBO Molecular Medicine. 9(8). 1067–1087. 100 indexed citations

13.

Doszpoly, Andor, Margaret R. Duffy, Lynda Coughlan, et al.. (2017). Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction In Vitro in the Presence of Mouse Serum. Journal of Virology. 91(12). 12 indexed citations

14.

Duffy, Margaret R., Andor Doszpoly, G. C. Turner, Stuart A. Nicklin, & Andrew H. Baker. (2016). The relevance of coagulation factor X protection of adenoviruses in human sera. Gene Therapy. 23(7). 592–596. 17 indexed citations

15.

Coussios, Constantin, Rachel Myers, James Kwan, et al.. (2016). Cavitation-mediated extravasation and transtumoral drug delivery by microstreaming: What role do the gas nuclei and the physical properties of the therapeutic play?. The Journal of the Acoustical Society of America. 140(4_Supplement). 2985–2985. 1 indexed citations

16.

Ma, Jiangtao, Margaret R. Duffy, Lin Deng, et al.. (2015). Manipulating Adenovirus Hexon Hypervariable Loops Dictates Immune Neutralisation and Coagulation Factor X-dependent Cell Interaction In Vitro and In Vivo. PLoS Pathogens. 11(2). e1004673–e1004673. 37 indexed citations

17.

Duffy, Margaret R., Alan L. Parker, Eric R. Kalkman, et al.. (2013). Identification of novel small molecule inhibitors of adenovirus gene transfer using a high throughput screening approach. Journal of Controlled Release. 170(1). 132–140. 10 indexed citations

18.

Duffy, Margaret R., Angela C. Bradshaw, Alan L. Parker, John H. McVey, & Andrew H. Baker. (2011). A Cluster of Basic Amino Acids in the Factor X Serine Protease Mediates Surface Attachment of Adenovirus/FX Complexes. Journal of Virology. 85(20). 10914–10919. 25 indexed citations

19.

Bradshaw, Angela C., Alan L. Parker, Margaret R. Duffy, et al.. (2010). Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X. PLoS Pathogens. 6(10). e1001142–e1001142. 64 indexed citations

20.

Duffy, Margaret R., Angela C. Bradshaw, Alan L. Parker, et al.. (2010). Abstracts7 ^th Annual MeetingGerman Society for Gene Therapy(DG-GT e.V.)Munich, LMU Campus Grosshadern, October 7–9, 2010. Human Gene Therapy. 21(9). 1169–1220. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact